Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Code Bio and Takeda collaborate on gene therapies for rare diseases

Feb. 23, 2022

New DNA Damage Response Consortium seeks to advance brain cancer research

Feb. 23, 2022

NovoBiome and Inserm collaborate on intestinal organoid-on-a-chip technology

Feb. 22, 2022

BioNTech and Medigene collaborate to develop TCR-based immunotherapies for cancer

Feb. 22, 2022

RosVivo signs material transfer agreement with Lilly for RSVI-301 for diabetes

Feb. 22, 2022

Repertoire Immune Medicines and UMass Chan collaborate to understand immune causes of vitiligo

Feb. 18, 2022

Neumora licenses rights to novel M4 receptor PAMs from Vanderbilt for schizophrenia

Feb. 18, 2022

Intellia and ONK enter licensing and collaboration agreement for allogeneic NK cell therapies

Feb. 17, 2022

Asep advances antibiofilm peptide technology for wound dressings

Feb. 17, 2022

Alamar and SciNeuro to discover and develop novel therapeutic antibodies for neurological diseases

Feb. 16, 2022

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...